Basic Materials / Specialty ChemicalsIstanbul
$20.20
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-203.6M · quality 47.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
30/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$15.3B
P/E
N/A
•EV/EBITDA
117.0x
↑ROE
-10.6%
↓Gross Margin
21.5%
↑Debt/Equity
0.15
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-5.6%
FCF CAGR
—
FCF margin
-6.7%
FCF / Net income
0.30x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $6.40B · net income $-1.44B · FCF $-431.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.40B | $6.40B | $7.09B | $8.09B | $7.61B |
| Net Income | $-1.44B | $-1.44B | $-828.9M | $1.08B | $2.18B |
| EBITDA | $273.5M | $273.5M | $772.7M | $2.10B | $2.30B |
| EPS | -0.97 | -0.97 | -0.56 | 0.29 | 0.58 |
| Gross Margin | 21.5% | 21.5% | 28.3% | 21.4% | 17.4% |
| Operating Margin | 8.5% | 8.5% | 15.3% | 11.0% | 10.6% |
| Net Margin | -22.5% | -22.5% | -11.7% | 13.3% | 28.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.15 | 0.15 | 0.11 | 0.09 | 0.12 |
| Current Ratio | 0.87 | 0.87 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-431.7M | $-431.7M | $-203.6M | $845.2M | $405.8M |
| Returns | |||||
| ROE | -10.6% | -10.6% | -4.1% | 6.6% | 21.2% |
| Valuation | |||||
| P/E | — | — | — | 9.35 | 4.17 |
| EV/EBITDA | 116.96 | 116.96 | 6.64 | 5.21 | 4.16 |
| P/B | 2.22 | 2.22 | 0.18 | 0.62 | 0.89 |
| Growth & Yield | |||||
| Revenue Growth | -9.8% | -9.8% | -12.3% | 6.3% | — |
| EPS Growth | -74.1% | -74.1% | -294.1% | -50.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+414.4%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.56 → -0.97
Residual
+414.4%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.